FDA Approves Epcoritamab for r/r B-Cell Lymphoma FDA Approves Epcoritamab for r/r B-Cell Lymphoma

Epcoritamab is the first subcutaneous bispecific antibody approved for the indication.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news